The expression of the c-erbB-2 receptor protein in glandular salivary secretions

Journal of Oral Pathology and Medicine

Volumn 33, Issue 10, 2004, Pages 595-600

  Streckfus, Charles F ^a   Bigler, Lenora ^a   Dellinger, Tracy ^a   Kuhn, Melinda ^a   Chouinard, Normand ^a   Dai, Xaoli ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

c erbB 2; HER 2 neu; Saliva; Salivary glands

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ADULT; ARTICLE; CANCER DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EXOCRINE GLAND; FEMALE; HUMAN; MEDICAL DECISION MAKING; MOUTH CANCER; MOUTH CAVITY; NIPPLE; NON INVASIVE MEASUREMENT; NORMAL HUMAN; ONCOGENE; PAROTID GLAND; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALIVA LEVEL; SALIVARY GLAND CARCINOMA; SUBLINGUAL GLAND; SUBMANDIBULAR GLAND; WESTERN BLOTTING;

ADULT; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MIDDLE AGED; PAROTID GLAND; RECEPTOR, ERBB-2; REFERENCE VALUES; SALIVA; SALIVARY GLANDS; STATISTICS, NONPARAMETRIC; SUBLINGUAL GLAND; SUBMANDIBULAR GLAND;

EID: 7944232779     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2004.00255.x     Document Type: Article

References (30)

1. Simon MA. Receptor tyrosine kinases: specific outcomes from general signals. Cell 2000; 103: 13-5.
2. Ouyang X, Gulliford T, Doherty A, et al. Detection of ErbB-2 oversignaling in a majority of breast cancers with phosphorylation-state- specific antibodies. Lancet 1999; 353: 1591.
3. Chen IH, Chang JT, Liao CT, et al. Prognostic significance of EGFR and Her-2 in oral cavity cancer in betel quid prevalent area. Brit J Can 2003; 89: 681-6.
4. Semba K, Kamata N, Toyoshima K, et al. A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland carcinoma. Proc Natl Acad Sci 1985; 82: 6497-501.
5. Breuer B, Smith S, Thor A, et al. ErbB-2 protein in sera and tumors of breast cancer patients. Breast Cancer Res Treat 1998; 49: 261-70.
6. Krainer M, Brodowicz T, Zeillenger R, et al. Tissue expression and serum levels of HER-2/neu in patients with breast cancer. Oncology 1997; 54: 475-81.
7. Volas GH, Leitzel K, Teramoto Y, et al. Serial serum c-erbB-2 levels in patients with breast carcinoma. Cancer 1996; 78: 267-72.
8. Lin YJ, Clinton GM. A soluble protein related to the Her-2 proto-oncogene product is released from human breast carcinoma cells. Oncogene 1991; 6: 639-43.
9. Rubin LA, Nelson DL. The soluble IL-2 receptor: biology, function and clinical application. Ann Intern Med 1990; 113: 619-27.
10. Zabrecky JR, Lam T, Mckensie SJ, et al. The extracellular domain of p185/neu is released from the surface of human breast carcinoma cells, SK-BR-3. J Biol Chem 1991; 266: 1716-20.
11. Kuerer HM, Thompson PA, Krishnamurthy S, et al. High and differential Expression of Her2/neu Extracellular domain in bilateral ductal fluids from women with unilateral invasive breast cancer. Clin Can Res 2003; 9: 601-5.
12. Streckfus CF, Bigler L, Tucci M, Thigpen JT. The Presence of CA 15-3, c-erbB-2, EGFR, cathepsin-D, and p53 in saliva among women with breast carcinoma. Cancer Invest 2000; 18: 101-9.
13. Streckfus CF, Bigler L, Dellinger TD, et al. The presence of c-erbB-2, and CA 15-3 in saliva and serum among women with breast carcinoma: a preliminary study. Clin Can Res 2000; 6: 2363-70.
14. Streckfus CF, Bigler L, Dellinger TD, et al. Reliability assessment of soluble c-erbB-2 concentrations in the saliva of healthy women and men. Oral Surg Oral Med Oral Path 2001; 91: 174-80.
15. Bigler LG, Streckfus CF, Copeland L, et al. The potential use of saliva to detect recurrence of disease in women with breast carcinoma. J Oral Pathol Med 2002; 31: 421-31.
16. Wick MR, Ockner DM, Mills SE, et al. Homologous carcinomas of the breasts, skin, and salivary glands: a histologic and immunohistochemical comparison of ductal mammary carcinoma, ductal sweat gland carcinoma and salivary duct carcinoma. Am J Clin Pathol 1998; 109: 75-84.
17. Navasesh M, Christensen C. A comparison of whole mouth resting and stimulated salivary measurements. J Dent Res 1982; 61: 1158-62.
18. Heft MW, Baum BJ. Unstimulated and stimulated parotid salivary flow rate in different age groups. J Dent Res 1984; 63: 1182-5.
19. Tylenda CA, Ship J, Fox PC, et al. Evaluation of submandibular salivary flow rates in different age groups. J Dent Res 1988; 67: 225-8.
20. Jenzano JW, Hogan SL, Noyes CM, et al. Comparison of five techniques for the determination of protein content in mixed human saliva. Anal Biochem 1986; 159: 370-6.
21. Legendre N, Matsudaira P. Purification of proteins and peptides by SDS-PAGE. In: Matsudaira P, ed. A Practical Guide to Protein and Peptide Purification for Microsequencing. San Diego, CA: Academic Press, Inc., 1989; 52-8.
22. SPSS. SPSS for Windows, Release 10.0. Chicago, IL: SPSS, 1999.
23. Dawes C. The effects of flow rate and duration of stimulation on the concentrations of protein and the main electrolytes in human parotid saliva. Arch Oral Biol 1969; 14: 277.
24. Dawes C. The effects of flow rate and duration of stimulation on the concentrations of protein and the main electrolytes in human submandibular saliva. Arch Oral Biol 1974; 19: 887.
25. Streckfus CF, Bigler L. The use of salivary protein markers for the detection and post-operative monitoring of cancer patients: an eight-year study. J Adv Dent Res 2004; in press.
26. Brinkley J, Copeland L, Streckfus C, Tucci M, Benguzzi H. Sustained delivery of HER-2/NEU antibody by TCPL delivery device using adult male rats as a model. Biomed Sci Inst 2003; 39: 324-8.
27. Bigler LG, Streckfus CF. A unique protein screening analysis of stimulated whole saliva from normal and breast cancer patients. Preclinica 2004; 2: 52-6.
28. Kurachi H, Okamoto S, Oka T. Evidence for the involvement of the submandibular gland epidermal growth factor in mouse mammary tumorgenesis. Proc Natl Acad Sci USA 1985; 82: 5940-3.
29. Nagler R, Kerner H, Ben-Eliezer S, et al. The prognostic role of apoptotic, Bcl-2, c-erbB-2, and p53 markers in salivary malignancies. Oncology 2003; 64: 389-98.
30. Nagler R, Kerner H, Laufer D, et al. Squamous cell carcinoma of the tongue: the prevalence and prognostic roles of p53, Bcl-2, c-erbB-2 and apoptotic rate as related to clinical and pathological characteristics in a retrospective study. Cancer Lett 2002; 186: 137-50.